塞马格卢提德载脂类纳米囊对代谢功能障碍相关的脂肪性肝病的影响
Inês Domingues1, Hafsa Yagoubi1, Wunan Zhang1
1UCLouvain, Université catholique de Louvain, Louvain Drug Research Institute, Advanced Drug Delivery and Biomaterials Group, Avenue Emmanuel Mounier 73, 1200, Brussels, Belgium.
Drug delivery and translational research
|April 13, 2024
概括
新的脂质纳米囊有效地输送西马格卢提德,改善葡萄糖平衡,并减少在代谢功能障碍相关的脂肪性肝病 (MASLD) 模型中的炎症. 这种口服纳米系统在缓解疾病进展方面比Rybelsus®更有效.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 纳米医学是一种纳米医学.
- 代谢疾病 代谢疾病
背景情况:
- 与代谢功能障碍相关的脂肪性肝病 (MASLD) 是一种普遍的疾病,缺乏经批准的药物治疗方法.
- 葡萄糖类1 (GLP-1) 类似物对MASLD有希望,但口服仍然是一个挑战.
- 脂质纳米囊 (LNC) 为口服药物输送提供了一个多功能平台,可能增强GLP-1活性.
研究的目的:
- 为了评估用于治疗MASLD和相关代谢综合征的塞马格卢提德载荷的LNCs.
- 为了比较口服LNC-semaglutide与市场上市的口服semaglutide (Rybelsus®) 的疗效.
- 评估对葡萄糖平衡,胰岛素耐药性,肝硬化和炎症的影响.
主要方法:
- 一个饮食小鼠模型 (西方饮食) 的MASLD被用于长期每日治疗超过4周.
- 塞马格卢提德被封装在LNC中,用于口服.
- 与口服Rybelsus®悬浮液进行了比较分析.
主要成果:
- 含有塞马格卢提德的LNCs对葡萄糖平衡和胰岛素耐药性产生了积极的影响.
- 没有观察到肝脂积累的显著变化,但炎症标志物有所改善.
- 这种LNC纳米系统在减轻代谢综合征和减少炎症方面表现出积极的趋势.
结论:
- 口服塞马格卢提德载荷的LNC显示在管理MASLD及其代谢并发症方面具有潜力.
- 在预防疾病进展方面,LNC策略似乎比Rybelsus®更有效.
- 对用于治疗MASLD的LNC进行进一步研究是有必要的.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
655
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
655
Overview of Lipid Metabolism
1.5K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.5K


